we have numbers out of amgen and we are waiting for facebook. that will determine how these tech stocks go. caroline: this is a beat. scarlet: as a result, amgen shares are moving higher in after-hours. maybe not. it closed at 189. joe: it looks like they are getting a bounce. scarlet: amgen is coming out with the beats, but we are waiting for facebook numbers as well. ahead of that, we want to bring in our panel of guests. david kirkpatrick, founder and ceo of tech economy -- techconomy. david, this has been a turbulent quarter. what investors care of facebook livers the numbers on daily active users and monthly active users? david: they want to see usage growing healthily in the developed countries like the united states where the profits are found. i think of facebook shows really good, surprising user growth, wall street will love it. i think a lot of the other data is going to be hard to make look good although i'm not sure we will see good user growth. joe: paul, if facebook once cut , for they- wants turn up the cash? >> i think they can

executives at amgen have credited mr. trump's tax cuts as a key reason they are doing that project here in rhode island. should you be thanking the trump administration for that? >> no, no. i take issue with what allan fung said about the economy, the lowest unemployment rates in 20 years, we have a record number of jobs in our state. there is more roadwork happening now than at any point in my lifetime. there are cranes in the sky. we trained 3000 people to our new approach to job training. the fact is the economy -- moderator: why would executives at amgen credit trump tax cuts if you don't? >> i think they said the tax cuts give them incentive to bring cash back to america and that is true, but they chose -- they could have gone anywhere. it was very competitive. some of the programs i startedthe mayor wants to unwind enabled that to happen. that is the creation of hundreds of high-paying manufacturing jobs that wouldn't happen if he became governor. they chose rhode island over other states because of what we have goi

drug amgen is the one you want.cynthia? >> caller: hi. my question today is about avengrid it's going down. >> yeah, all the utility stocks are going down the two i'm recommending are dominion now it's finishing the south carolina situation, but more important, aep. werner in florida. werner >> caller: mr. cramer, thank you for taking my call before we start, though, my wife just mentioned that she had heard you had recently lost a pet. >> yeah, yeah, we did. >> caller: and i just lost two beautiful dogs so we have your heartfelt sympathy. >> thank you we had to put bug down because of a tumor and everybody who owns -- who knows animals or has one knows that this is far more painful than you ever thought before you ever owned one so thank you so much and i'll certainly tell that to louisa i'll pass that on. how can i help >> caller: okay. my wife got some information from her investment business daily first part of the year on a company called crispr. >> investors business does a very good job. that's a momentum sto

amgen, i think is way too much today. it's a good opportunity. and now here's a problem we've got amazon, apple, and adobe. these are going to trade together, as we saw today. so i would keep apple. keep amazon. that's two that are together and then the other i would indeed toss. all right. well that adobe should go. amazon and apple should say. "mad money" is back after the break. this is huntsville, alabama. aka, rocket city, usa. this is a very difficult job. failure is not an option. more than half of employees across the country bring financial stress to work. if you're stressed out financially at home, you're going to be too worried to be able to do a good job. i want to be able to offer all of the benefits that keep them satisfied. it is the people that is really the only asset that you have. put your employees on a path to financial wellness with prudential. bring your challenges. the nation's largest senior-living referral service. for the past five years, i've spoken with hundreds of families and visited senior-care communities around t

the move could help boost amgen's share in the u-s market.eather) coming up i'll have the seven day lawrence this is a fight. not to the finish. but to the beginning. a fight that can only be won, if we stand together for one cause. him. expert care for every new beginning. ♪ ♪ ♪ the holidays begin here at the disneyland resort. minutes can mean the difference between life and death. proposition 11 saves lives by ensuring medical care is not delayed in an emergency. proposition 11 establishes into law the longstanding industry practice of paying emts and paramedics to remain on-call during breaks and requires they receive fema level training and active shooters and natural disasters. vote yes on 11 to ensure 911 emergency care is there when you or your love one need it. california's public schools rank 44th in the nation. 44th. i'm marshall tuck, i'm a public-school parent, and i know we can do better. in the public schools i led, we got more funding into our classrooms, supported our teachers, and on rates by 60%. that's why president obama'

amgen said, it is immediately cutting the price of repatha.. by 60- percent... from about 14- thousand dollars to 5- thousand- 800 dollars a year. the company's c-e-o says, the cut will particularly help medicare benificiaries. many people now face out- of- pocket costs of 370 - dollars per month. that will drop to 25- to 150- per month... depending on their prescription plan. this move could help boost amgen's share in the u-s market. (ken) a big story tonight... crews are racing against the clock to repair yet another piece of cracked glass at san francisco's millennium tower. (pam) they want to remove the cracked glass... before the city makes them put up safety scaffolding along fremont street. kron-4's dan kerman has the lastest. it's here between floors 9 and 10 on the fremont street side of san francisco's millennium tower where a second piece of cracked glass was discovered by engineers conducting a visual inspection demanded by the city.sot william strawn/sf dept. of building inspectiona horiziontel piece of glass which im told is for cosmetic purposes

why would executives at amgen credit the trump tax cuts if you don't? gov. raimondo: i think what they said on account of some of the tax cuts they gave them to bring some of the cash back to america. i think that is true. but they chose rhode island -- they could have gone anywhere. in fact, it was very competitive. some of those programs that started that the mayor wants to unwind enabled to that happen. that would mean -- that's the creation of hundreds of high-paying manufacturing jobs. that wouldn't happen if he became governor. they chose rhode island over other states because what we have going on. actually, they mainly chose us because of our job-training program. they want to hire rhode islanders. that's why companies come here. >> you can't deny the national economy is humming now. gov. raimondo: yes, but our economy is doing better than average. we have a number one wage growth in america. our progress isn't by accident, and our progress isn't because of the president. our progress is because we came together four years ago and decided to change t

>>> late tad amgen says it's cutting the price of a anti-cholesterol crewing to 60%. bring going down to $5,800 lower ritient co-pays and barrier erected by shurz resulted in disappointing sales. the compaes making rival drugs have announced rebates and discounts earlier this year. >>> exxonmobil was sue by the new york attney general by for misleading investor on climates . the suit alleges the company did not sell investors about the true riskses to the bus posed by climate change regulations. the lawsuit does not charge the tp company with contributing to climate change or suppressing climate science. it does claim that the former ceo rex till erds was aware of the fraudulent vior. >> upon a day when extra attention is paid to the tech sector the ceo of apple had harsh words for howther silicon valley company manage data they collect. during a privacy conference in brussels todayoo tim said personal information has been weaponized in his words. but he stopped short of naming facebook and google specifically, two of the largest companies making money byin se ads. >>

amgen closed down when 5%. not really move management after hours.is because the drug didn't become a big money maker because there was reimburse 7menreimabo reimbursement trouble due to the price. and amgen gives credit to the trump administration showing it shows support to try to lower drug prices. and this is a day before president trump will give a speech about drug prices tomorrow so you can see it was a bad day biotech. >> and still interesting development. >>> and two executives taking a leave of absence at wells fargo. the company just announcing that its achieved a minuchief david julian have begun a leave of absence from wells fargo and no longer members of the company's operating committee. the leaves relate to previously disclosed ongoing reviews by regulatory agencies which is in connection with the historic retail banking sales practices they are unrelated to the company's reported financial results or internal financial controls so continuing fallout over the retail sales practices of wells fargo two executives taking a leave of absen

and amgen is up 3%. biotech has been under pressure. the health care trade overall has been a hot trade everyone is talking about. let's talk about it in the bloomberg. i moderated a panel last night and the one concern was biotech. taking a look at health care over the last three months, health care is outperforming. up six and have percent. -- half percent. biotech is down 3%. that is in white. some of the panels were saying they like to see biotech continue to bounce back. they got it today. scarlet: abigail, we will jump in here with breaking news. netflix reporting its earnings. revenue was billion dollars matching the estimate. the big number is fourth-quarter total streaming net change. an additional 9.4 million. that is the outlook for this quarter. for the third quarter that just ended, 6.9 6 million was the third-quarter total net change and analysts were looking for 5.09. a big beat. caroline: the after-hours share prices are up almost 12 percentage points. paul, what do you think about these earnings? >> we've talked about e

i amgen fer casarian and i work here at san francisco international airport. the idea for therapy dogs got started the day after 9/11. an employee brought his therapy dog to work after 9/11 and he was able to see how his dog was able to relieve passenger's jitter. when we first launched the program back in 2013, our main goal was to destress our passengers however what we quickly found is that our animals were helping us find a way to connect with our pang. passengers. we find there are a lot of people traveling through the airport who are missing their pets and who are on their road a lot and can't have pets and we have come in contact with a lot of people recently who have lost pet. >> i love the wag brigade. >> one of my favorite parts is walking into the terminals and seeing everybody look up from their device, today everybody is interacting on their cell phone or laptop and we can walk into the terminal with a dog or a pig and people start to interact with each other again and it's on a different level. more of an emotional level. >> i just got off an 11.

let's get back to policy >> that would be great last night amgen, they cut the price dramatically theyd medicare wasn't covering it. when you see a decline in the price of a drug, does that hit you and say that's at a level that's reasonable for the co-pay, we're going to cover it? how does it work >> we have to have a therapeutic coverage of any disease. so if there's a product that's similar to it that's not as expensive, and only physicians make that decision, and they say that product should not be added to it, it's done we don't make that decision. i depend on physicians to do it. we are very much physician driven >> that's great. the last question i have, it's kind of one that people have, do people in this country know what open enrollment nene menment mes >> i'm not sure they do. we've had 80% reen rollment. i don't know that they understand and what the process is >> i'm glad you mentioned that, because that's a real problem for people watching the show that's chairman and ceo of centene. they've got a december '14 analyst meeting. you want to be in this stock before it happen

amgen said, it is immediately cutting the price of repatha.. by 60- percent...ut 14- thousand dollars to 5- thousand- 800 dollars a year. the company's c-e-o says, the cut will particularly help medicare benificiaries. many people now face out- of- pocket costs of 370 - dollars per month. that will drop to 25- to 150- per month... depending on their prescription plan. this move could help boost amgen's share in the u-s market. ( robin ) seven children have died and a dozen others were sickened by an virus outbreak at a nursing and rehabilitation center in haskell, new jersey. a-deno-viruses typically cause mild illness in young kids.but health officials say the number seven strain of the virus found at the facility is -- quote -- "affecting medically fragile children with severely compromised immune systems." officials say the strain is usually associated with a disease in communal living spaces. a state department of health team has found minor handwashing deficiencies at the center. the facility will not admit any new patients until the outbreak ends. there is

i took 20% off my adobe, 50% off my amazon, loaded up on avid, amgen and pfizer. for folks at home, these are defensive names. they are all not only pharmaceuticals, the health care sector has been leading now for maybe nine months, being led by pharma names. these are also dividend payers. if you are getting frightened this is one way you can go. liz: alan, tell us what you were doing, because i like to let our viewers know how traders react and think. they may be in for a much longer term for their portfolio, but it's interesting to let people in and see this window regarding how you behave when you start to see this many headlines. that's what's newsworthy about this, i think. >> yeah. well, i was looking for more of a flush-out than we have actually seen. i look to see how the markets test, their retracement levels, about 50% sell-off. if you look at the stock market and s&p it rallied up to 2825, a halfway bounce of that larger sell-off. today, we went down to 2760, halfway level of the halfway. so looking to see if the support holds but i use these kind of o

shares of amgen are up 8% for the year. there's the year-to-date chart for amgen, 2018.hance to win big. no one won last night's powerball. the jackpot is $750 million, the fourth largest lottery jackpot in's history, not as big as the $1.5 billion mega millions jackpot that was won in south carolina on tuesday night. powerball prize has been growing since august 11th. the next chance to win is going to be on saturday. then there is this. friends star david schwimmer swears he is not wanted for stealing beer in the u.k. we brought you this story yesterday. schwimmer posted a video on instagram, proving his alibi, that he was in new york. it was surveillance like video. he seems suspiciously clutching a case of cans as he leaves a convenience store. there's' schwimmer, that's actually him. this is after a security camera screen grab was posted of this guy, it was posted on facebook, an international joke. the real guy that's wanted for stealing beer in the u.k. looks like david schwimmer. a lot of fun with this one. dagen: a shoplifter making david schwimmer relevant agai

you get the amgen, gilead. biogen you don't have to to worry about the one offs something down 30% gill idea has help cphiv and trying to replace the ceo. a lot of headwinds for one stock. >> check out where we stand with the after hours movers amazon still down. intel managing in the green. higher by 3.2% we tell kwhau the c suite is telling wall street. plus heading to bear country not dan nathan's house stand back in stocks nearly half of the s&p 500 in bear mechanic. is this the chance to buy? there is more "fast money" on the busy earnings night right after this hey, what are you guys doing here? we're voya. we stay with you to and through retirement. so you'll still be here to help me make smart choices? well, with your finances that is. we had nothing to do with that tie. voya. helping you to and through retirement. >>> oh, no really sfl. >> welcome back to "fast money." everything apparently is awesome on wall street stocks making the come back. the dow surging 400 points after yesterday's 600 point sel

facebook the big one obviously but watching electronic arts mgm reports and amgen. and julia boorts isn't all over the earnings call for facebook we check back with her a in a few moments. but first the market valuey and stocks fighting back at least for today the dow jumping 400 points surging into the close the s&p climbing out of correction territory is this another head fake or maybe the rolly for feel. >> it's another head fake if you want me to answer the question. >> an honest answer. >> it is an honest answer. >> always appreciate it. >> a first for everything. >> no. no that's not true. come on, tim you no he that. >> you're right. >> i'm an honest person. >> sometimes i dance around the question but i wind up answering. i will answer again. it's a head fake if the s&p can maybe recapture 27109 thirt handles or so and close above that for a couple of days we have a conversation. but i think this is a head fake and moving lower with the 1.5% today there is another 4.5% to the downside the vix in my opinion if we had a true move the vix should have closed clo

facebook the big one obviously but watching electronic arts mgm reports and amgen.ings call for facebook we check back with her a in a few moments. but first the market valuey and stocks fighting back at least for today

there is a new set of drugs from amgen that lower cholesterol levels more.hey are given by inskreks and they are pricey. joining us is esperion's ceo tim mayleben thank you for being here so tell us about these new data and where you see your drug fitting into that paradigm if it's approved. >> sure. the data we announced earlier this week, as you said, we dropped cholesterol, it's an oral once a day pill, and it demonstrated that you could lower cholesterol by 20% on top of the most prescribed drugs, statins, and was safe and well tolerated as well. and what we see this drug being used as is for, as you mentioned, the one in three people today who are taking a statin or taking the maximum dose of a stat in that they can tolerate and not getting to their ldl cholesterol low are goal again, one in three patients we think will be able to get to goal that are not getting to goal today. >> these patients typically are patients that have had cardiac events so heart attack or a stroke. there are maximum statin dosages and they still can't lower their bad cles all

. >> not like the stocks are falling on this news i can tell you those prospects amgen is not falling know that they don't necessarily collect a list price so if this is done by list price, we don't really know if it's going to impact the profitability of the companies >> that's true it's an interesting situation, as to how this will actually affect drug companies. you're right it's not affecting stocks right now a lot of this had been telegraphed already. a lot f people wewere looking fo come president obama and the president obama tried to change the way we changed for things in medicare part "b," too, and that didn't play out because there was so much opposition from the industry people say doctors and hospitals might not like this, either, because people say there's an incentive for doctors to use higher-priced drugs. the way medicare part "b" drugs are currently paid for, paid for at basically the price of the drug plus 6%. >> thank you >> thank you >>> the oil market closing for the day. jackie deangelis has the details from the cnbc commodity desk. >> hey there, scott. crude oi

as you can see amgen and eli lilly up teva is down this morning. credit suisse he's concerned about the impact of higher interest rates on the housing market and what he calls the decoupling of the housing market with these stocks in particular we'll talk more about this a little later this morning. also, general electric will reportedly win a $15 billion power generation contract. the ft says that germany siemens was close to the deal. but put pressure on to award the contract to a u.s. company >>> united continental raising guidance after posting its best quarterly revenue growth since 2010 phil lebeau joins us now with a special guest. good morning, phil and good morning, mr. munoz. >> hey, joe. how are you? oscar munoz. this is one of those mornings you're happy to come on because you have strong performance in the third quarter. what stands out when you look at the numbers you posted for this last quarter >> it's a combination of the plan we put together right? it's a journey from getting our people back together, getting our union structure w

i missed it >> did you get all of them >> in the question, it had ph -- like one of those form -- amgeni lilly -- >> oh, wow >> i can't believe it. number one i can't believe i was watching "jeopardy!. >> you've admitted before. >> i have. and i was thinking of awe alyou. i was going to call meg. >>> meantime, social stock, julia borstein joins us with more >> good morning, the social stock snap to a new low. shares of snap plummeting 20% losing 6% yesterday alone. this was dragged down by the analyst michael nathanson saying the company is quickly running out of money facebook shares are down nearly 7% over the last five trading sessions down 4% yesterday alone. that company is suffering from revelations of a security bug at whatsapp that allowed hackers to take a user's applications when they answered an incoming video call that is the latest in a string of privacy concerns. twitter shares fell 8.5% yesterday. that's the second worst performing stock in the s&p 500 following tiffany. in addition to the broader selloff, all of these companies are facing the risk of pending regulation,

check out stocks like amicus, exelixis and blue byrd, and the larger cap, amgen and gilead are holding up there divergence becomes more clear over the last month. the ibb weighted more towards larger cap stocks is down significantly less than the xpi. a couple reasons for the divergence one could be rising interest rates or just the fear of rising interest rates it's held that biotechs will suffer in higher rate environments but it was analyzed of 20 years of the relationship between biotech performance and the ten-year yield they found in the five periods when it increased so did the nasdaq biotech index that, guys, could be playing into what we're seeing now. >> just in terms of the broader healthcare move, meg, actually it's the best performing sector in the s&p so far this year, up about 12%. it's getting hit with the rest of the market today. a lot of people looking to healthcare for a leadership position if this market can turn around and say there's a lot of value there. how do you see it? >> break it up into the sections, biotech the most momentum driven there, aetna and the he